Key result
Reperfusion strategies and clopidogrel loading in STEMI yield unspecified effects on short-term outcomes.
Why the study?
Despite advances in pre-hospital care, shorter intervention times, and recommended treatments, STEMI remains the leading cause of in-hospital death.
Do reperfusion strategy, clopidogrel loading doses, and adjunctive therapy affect short-term mortality and morbidity in patients with STEMI?
Observational
Do reperfusion strategy, clopidogrel loading doses, and adjunctive therapy affect short-term mortality and morbidity in patients with STEMI?
Short-term STEMI effects remain undetermined despite RCT; leaves open optimal reperfusion and antiplatelet strategies for future trials.
Objective: Despite the transfer of the treatment process to pre-hospital settings, shortening of intervention times, and implementation of recommended treatment options, ST-elevation myocardial infarction (STEMI) remains the leading cause of in-hospital death.In our study, the contribution of the reperfusion strategy, clopidogrel loading doses, and adjunctive therapy on platelet aggregation to mortality and morbidity was investigated.
No takes yet. Share an insight, caveat, or question.
Yağmur et al. (2023) conducted an observational in ST-elevation myocardial infarction (STEMI). Reperfusion strategy, clopidogrel loading doses, and adjunctive therapy was evaluated on Mortality and morbidity. The effects of reperfusion strategy, clopidogrel loading doses, and adjunctive therapy on short-term mortality and morbidity in STEMI were investigated, though specific results are not provided.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: